Back to News
Market Impact: 0.1
Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference
Source: globenewswire.com
Healthcare & BiotechManagement & Governance
Immuron CEO Steven Lydeamore is scheduled to present virtually at the Emerging Growth Conference on October 28, 2026, from 4:25 p.m. to 4:55 p.m. U.S. Eastern Time. The announcement provides no financial results, guidance, or other material business updates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
IMRN0.10
More News
- Ready for a French test?: Five questions for the ECB
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
- Moderna shares plunge after leak of partial cancer vaccine data
- Meta stock sinks 6% as AI spend pushes free cash flow negative
- Moderna's stock tumbles after reported leak of data for cancer vaccine
- Palmer Luckey teams with dire wolf billionaire Ben Lamm to launch $200 million Warhound, unleashing genetically engineered clone dogs of war